Close Menu

NEW YORK – While it's unclear whether or not the US ever exited the first round of the SARS-CoV-2 pandemic, many fear another wave of infections could hit in the fall when the country will enter its typical high season for respiratory viruses.

Preparing for such a wave will present a number of challenges for the lab industry, foremost among them the continued difficulties around reaching sufficient test capacity and the issue of other respiratory infections like influenza complicating the diagnostic picture.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.
Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

Sponsored by

Developing a fully integrated consumable cartridge for an automated diagnostic platform is a significant challenge. More challenging still is developing such a cartridge in response to a deadly global virus pandemic amid market uncertainty and extraordinary time constraints.